Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3441 studies found for:    "Prostatic Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Prostatic Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition: Prostatic Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
3 Active, not recruiting Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: METFORMIN;   Drug: Placebo;   Drug: TAXOTERE®
4 Completed Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients
Condition: Prostatic Neoplasm
Interventions: Behavioral: Walking Intervention;   Other: Standard of Care
5 Terminated Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: GM-CSF;   Drug: Ketoconazole;   Drug: Mitoxantrone
6 Completed Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Atrasentan
7 Completed Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Intervention: Other: No Intervention
8 Terminated A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: CFG920
9 Completed Safety Study of TAK-700 in Subjects With Prostate Cancer.
Condition: Prostatic Neoplasms
Intervention: Drug: TAK-700
10 Recruiting A Registry of Participants With Prostate Cancer in Asia
Condition: Prostatic Neoplasms
Intervention: Other: No Intervention
11 Completed Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: VELCADE TM (bortezomib) for Injection
12 Completed
Has Results
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Drug: triptorelin embonate (INN)
13 Active, not recruiting Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
Conditions: Prostatic Neoplasms;   Low Grade Prostate Cancer
Interventions: Other: Dietary intervention first;   Drug: Drug (Dutasteride) intervention first
14 Completed Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Biological: TroVax;   Drug: GM-CSF
15 Completed Efficacy and Safety Study of Xyotax to Treat Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Paclitaxel polyglumex (Xyotax)
16 Completed
Has Results
Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Prednisone;   Drug: SU011248
17 Completed Phase II Study of ASP3550 in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: ASP3550
18 Terminated Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: GM-CSF;   Drug: thalidomide;   Drug: docetaxel
19 Recruiting Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Enzalutamide;   Drug: Conventional NSAA;   Drug: LHRHA;   Radiation: External Beam Radiotherapy (78 Gy in 39 fractions or 46 Gy in 23 fractions plus brachytherapy boost)
20 Recruiting Collection of Blood From Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.